Up for the challenge
This article was originally published in SRA
Executive Summary
Aginus Kalis, head of the Dutch Medicines Evaluation Board and chair of the management group of the EU Heads of Medicines Agencies, tells Maureen Kenny about the challenges involved in implementing the new EU pharmacovigilance legislation, especially in view of the fact that no extra funding is available.